Can paclitaxel be replaced with docetaxel in a patient who developed erythema multiforme, while continuing treatment with carboplatin? Is there a risk of cross-hypersensitivity between paclitaxel and docetaxel?
There is indirect evidence of a significant risk of cross-hypersensitivity between paclitaxel and docetaxel, especially in patients with prior hypersensitivity reactions. Careful monitoring and use of premedications are recommended when considering such a switch in treatment.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5281/zenodo.24195383
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00